1 Motohiko Kato, Tsutomu Nishida, Katsumi Yamamoto, Shiro Hayashi, Shinji Kitamura, Takamasa,Yabuta, Toshiyuki Yoshio, Takeshi Nakamura, Masato Komori,6.

Slides:



Advertisements
Similar presentations
T1 colonic carcinoma – Is endoscopic resection sufficient? HC Yip JHGR 21/7/2012.
Advertisements

Polyps – Where do they come from and what do you do with them?!
State-of-the-art in the Surgical Treatment of Gastric Cancer in Shanghai Department of Surgery Rui Jin Hospital School of Medicine, SJTU.
Impact of Lymph-Node Metastatic Site in Patients with Thoracic Esophageal Cancer Edited by: Kunisaki C., Makino H., Kimura J., Oshima T., Fujii S., Takagawa.
Management of Difficult Colonic Lesions
Editor: DrMohammad Sadrkabir. Magnifying Narrowband Imaging Is More Accurate Than Conventional White-Light Imaging in Diagnosis of Gastric Mucosal Cancer.
Characteristics of submucosal gastric carcinoma with lymph node metastatic disease H J Son, S Y Song,1 S Kim,3 J H Noh,2 T S Sohn,2 D S Kim1 & J C Rhee.
Malignant colonic polyp: endoscopic treatment updates
Dr. LF Hung Department of Surgery, Tuen Mun Hospital, HKSAR
A REVISIT TO MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOUR (GIST) Joint Hospital Surgical Grand Round 17 Jan 2015 Grace Liu Pamela Youde Nethersole Eastern.
Prevalence of Helicobacter pylori infection in chronic dyspeptic patients with peptic ulcer in Naresuan University Hospital Researchers Rutnumnoi Thanachat.
Description of fracture with endocrine therapy use in older breast cancer survivors in a population-based setting Taryn Becker 123, Geoff Anderson 123,
GASTRIC LYMPHOMAS Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.
ENDOSCOPIC FEATURES IN PATIENTS WITH MARGINAL ZONE LYMPHOMA OF MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT) IN A FOLLOW UP OF 10 YEARS 1 N.V. Chrysanthos,
THE SIGNIFICANCE OF HISTOLOGICAL SUBSTAGING IN CURATIVE RESECTED T3 COLORECTAL CANCER Karl Mrak & Jörg Tschmelitsch Department of Surgery, Barmherzige.
Se cond Cancers and Residual Disease in Patients Treated for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma by Helicobacter pylori Eradication and.
Should colonoscopy be performed one year out from colorectal cancer resection? Alexandra Kent, Philip Thompson, Prof Alan Horgan, Mr Paul Hainsworth Newcastle.
National Oesophago–Gastric Cancer Audit Key Findings from 2014 Annual Report and Progress Report Georgina Chadwick Clinical Research Fellow.
Dr Poonam Valand, Foundation Year Two Dr Anjan Dhar, Consultant Gastroenterologist COUNTY DURHAM AND DARLINGTON NHS FOUNDATION TRUST Early gastric cancer.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.
Practice of Endoscopic Mucosal Resection: A Survey to Endoscopic Units in Europe Class 15 – FMUP – 2008/ th December 2008 André Carvalho, Ana Morais,
Gastric Cancer Gidon Almogy MD Department of General Surgery Hadassah University Hospital.
 Detection of metachronous tumors  Recognition of local recurrence Follow-up Flexible endocsopy.
The role of Endoscopy in Gastric Cancer Fergal Donnellan Gastroenterologist VGH.
Towards Global Eminence K Y U N G H E E U N I V E R S I T Y Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society.
R3 정명화 /Prof. 장재영 Gastrointest. Endosc. 2012; 75:39-46.
건강검진을 위해 내원한 74 세 여자 환자 연세대학교 원주의과대학 원주기독병원 소화기내과, 1 병리과 석기태, 조미연 1, 김현수.
위암병리보고서의 기재사항 서울대학교 김 우 호.
Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.
Association of Family History with Cancer Recurrence and Survival in Patients with Gastric Cancer Journal of Clinical Oncology : R2 Hwang.
The incidence of deep vein thrombosis in Japanese patients undergoing endoscopic submucosal dissection Masafumi Kusunoki, MD, Kazumasa Miyake, MD, PhD,Tomotaka.
Review R4 황은정 경희대학교 의과대학 소화기내과.
Effect of Helicobacter pylori Eradication on Metachronous Recurrence After Endoscopic Resection of Gastric Neoplasm Am J Gastroenterol 2014; 109:60–67.
R3 정상완. Introduction  EGC : Tumor invasion is limited to the mucosa or submucosa, regardless of lymph node involvement.  Accumulated histopathological.
GASTROINTESTINAL ENDOSCOPY Volume 78, No. 5 : 2013 F1 김태영 Katsuhiko Higuchi, MD, PhD, Satoshi Tanabe, MD, PhD, Mizutomo Azuma, MD, PhD, Chikatoshi Katada,
GI conference Case 3 Stomach and liver F/69 S
D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer NEJM July vol 359 R2 임규성.
Eradication of Helicobacter pylori After Endoscopic Resection of Gastric Tumors Does Not Reduce Incidence of Metachronous Gastric Carcinoma Clinical Gastroenterology.
Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia: an analysis using the Vienna classification R1 김진숙 / Prof. 장재영.
High frequency of early colorectal cancer in inflammatory bowel disease M W M D Lutgens, F P Vleggaar, M E I Schipper, P C F Stokkers, C J van der Woude,
Should Elderly Patients Undergo Additional Surgery After Non-Curative Endoscopic Resection for Early Gastric Cancer? Long-Term Comparative Outcomes R3.
Long-term outcomes of combination of endoscopic submucosal dissection and laparoscopic lymph node dissection without gastrectomy for early gastric cancer.
Long-term outcomes of endoscopic submucosal dissection (ESD) for superficial esophageal squamous cell neoplasms Satoshi Ono, MD, Mitsuhiro Fujishiro, MD,
Staging of rectal cancer by EUS: depth of infiltration in T3 cancers is important Christian Jürgensen, MD, Andreas Teubner, MD, Jörg-Olaf Habeck, MD, Friederike.
Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status : prospective endoscopic cohort.
Date of download: 7/11/2016 From: Estimating Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer: A Cohort Study Ann Intern Med. 2012;157(11):
Hye Won Lee Hyuk Lee Hyunsoo Chung Jun Chul Park Sung Kwan Shin Sang Kil Lee Young Chan Lee Jung Hwa Hong Dong Wook Kim The efficacy of single-dose postoperative.
KShotaro Nakamura,1 Toshiro Sugiyama,2 Takayuki Matsumoto,1 Katsunori Iijima,3 Shouko Ono,4 Masahiro Tajika,5 Akira Tari,6 Yasuhiko Kitadai,7 Hiroshi Matsumoto,8.
R3 김재민 / Prof. 장영운 Journal conference 1.
Indications for gastrectomy after incomplete EMR for early gastric cancer Hideki Nagano1,4, Shigekazu Ohyama1, Tetsu Fukunaga1, Yasuyuki Seto1, Junko Fujisaki2,
Brain imaging prior to lung cancer resection
Comparison Between Definitive Chemoradiotherapy and Esophagectomy in Patients With Clinical Stage I Esophageal Squamous Cell Carcinoma Sachiko Yamamoto MD,
Oesophago–Gastric Cancer
Figure #1 Overall survival Figure #2 Disease free survival
Detectie van recidiverend rectumcarcinoom tijdens follow-up
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Prognosis of younger patients in non-small cell lung cancer
Oesophago–Gastric Cancer
HEPATIC RESECTION FOR PARENCHIMATOUS OVARIAN CANCER LIVER METASTASES BEYOND SECONDARY CYTOREDUCTION FOR RELPASED OVARIAN CANCER Nicolae Bacalbasa1,
Contribution by Prof. Dr. B.L.A.M. Weusten
Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma
Intraluminal Endoscopic Surgery: The Scioto Returns
Volume 137, Issue 5, Pages e2 (November 2009)
Nonpolypoid (Flat and Depressed) Colorectal Neoplasms
National Oesophago-Gastric Cancer Audit 2018 Annual Report: Slide set
The STAR-TREC Trial SIV Presentation
Volume 1, Issue 3, Pages (November 2016)
ESD and beyond – The benefits of “getting it early”
Surgical resection of metachronous liver metastases
Presentation transcript:

1 Motohiko Kato, Tsutomu Nishida, Katsumi Yamamoto, Shiro Hayashi, Shinji Kitamura, Takamasa,Yabuta, Toshiyuki Yoshio, Takeshi Nakamura, Masato Komori,6 Naoki Kawai, Akihiro Nishihara, Fumihiko Nakanishi, Masanori Nakahara, Hideharu Ogiyama, Kazuo Kinoshita, Takuya Yamada,Hideki Iijima, Masahiko Tsujii, Tetsuo Takehara Gut 2012;0:1–8. doi: /gutjnl F1 김혁 / Prof 장재영

Introduction Gastric cancer : new cases and deaths annually Early gastric cancer, LN(-) –the 5-year gastric cancer-specific survival rate is 99% in Japan Endoscopic Resection (ER) : Endoscopic Submucosal Dissection (ESD) –preserves the entire stomach and the patient’s quality of life (QoL) –Gastric cancer generally arises from H pylori associated chronic gastritis –Preserving the stomach contributes to maintaining postoperative QoL but could increase the risk of multiple cancer development from the remnant gastric mucosa –Follow-up is important for detecting multiple cancers after ER 2

Aim To elucidate the patterns of multiple cancer development from remnant gastric mucosa To determine whether scheduled endoscopic surveillance can control multiple cancers after successful ER 3

PATIENTS AND METHODS 4 1.Multicenter retrospective cohort study 2.12 hospitals participating in the Osaka University ESD Study Group 3.Approved by the Osaka University institutional review board 1 university hospital, 5 secondary care hospitals and 6 tertiary care hospitals

PATIENTS AND METHODS 5 Underwent curative ESD : ~ Three groups proposed by Gotoda –Guideline group mucosal differentiated cancer, largest diameter <20 mm –Expanded guideline group differentiated cancer, largest diameter >20 mm differentiated cancer with ulceration, largest diameter <30 mm differentiated cancer, largest diameter <30 mm, submucosal invasion <500 μm –Non-curative group did not meet these criteria

PATIENTS AND METHODS 6 Multiple gastric cancer development –Synchronous cancer (within 1 year) Concomitant cancer : diagnosed before the initial ESD Missed cancer : being detected within 1 year but not detected at the time of the initial ESD –Metachronous cancer (after 1 year)

PATIENTS AND METHODS 7 Investigated the methods preoperative screening by questionnaire How often was each endoscopic modality used for preopertive screening? How much experience does an endoscopist need to be allowed to perform preoperative screening in your hospital?

PATIENTS AND METHODS 8 First f/u EGD within 1mon : 30% First f/u EGD within 3mon : 41% First f/u EGD within 6mon : 100% Surveillance EGD : every 6–12 mon Abdominal CT : by final pathological diagnosis Follow-up protocols

RESULTS 9 Prognosis-chasing rate : 97.9% Mean observation period : 26.8 months

RESULTS 10 Not significantly differ between patients with and without multiple cancers -Location -Size -Macroscopic type -Histological type -Invasion depth -Guideline classification 13.9%

RESULTS 11 19% Synchronous cancer -21 missed cancers - Median time to detection : 6.3 months -The mean diameter : 21mm -Upper third of the Stomach : 33% -Lesser curvature or posterior wall : 81% -Submucosal invasion : 3 -Muscularis propria invasion : 1

RESULTS % 16% Metachronous cancer - increased linearly

RESULTS 13 Successful H pylori eradication : no difference in the cumulative incidence rate of multiple cancers Because….. -Study design -Observation period

RESULTS 14 Treatment-related Deaths : 0 % The 3-year overall survival rate : 96.8% Disease-specific survival rate : 100% 96.8%

RESULTS 15 Surveillance EGD -at least once a year after the ESD hospitals Massively invading cancer -more than 1 year after ESD occurred in only one Based on these findings, we recommend that annual surveillance be performed

Conclusions This is the first multicenter study of long-term outcomes after ESD for EGC One of the largest to date Incidence of synchronous cancer rate : 9% –19% of synchronous cancers were missed Incidence of metachronous cancer : increased linearly With an annual follow-up examination, almost all multiple lesions could be cured by ER. 16